Alternations in markers of insulin resistance: HOMA-IR, HOMA-B, QUICKI, after dual therapy combination with telmisartan/amlodipine in prediabetic hypertensive patients
7 April 2022 (09:30 - 14:00)
Organised by:
About the speaker
University hospital of Ioannina, Ioannina (Greece)
282 More presentations in this session
Miss C. Chaudron (Montpellier, FR)
Professor P. Jankowski (Warsaw, PL)
Access the full session
The Event
ESC Preventive Cardiology 2022
7 April - 9 April 2022
You may be interested in
Congress Presentation
